Category Archives: Medicine

Prof. Lucien Abenhaim: There is an incredible challenge for the sustainability of health systems across the world

Prof. Lucien Abenhaim

LONDON, Dec-3-2017 — /EuropaWire/ — On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations convene in London (UK) to address the mounting challenge of accessibility and patient access to high-value, high-cost medical therapies.

The not-for-profit executive forum is organised by the London School of Hygiene and Tropical Medicine and analytica|LASER, a global research consultancy, to investigate topical questions around drug policy, global health systems sustainability and innovation funding through a combination of case studies, panel sessions, and roundtables. Delegations are registered from over 70 public and private organisations, including the World Health Organization, as well as health systems representatives from Belgium, England, Estonia, Croatia, France, Germany, Italy, Norway, Sweden, the United States and Wales. Multiple patient organisations support the meeting to ensure that the patient voice is reflected in all deliberations.

“Access to life-saving drugs is not a new challenge. The paradigm of accessibility was changed completely in the face of the deadly HIV epidemic. This time, however, accessibility concerns almost every domain of medicine such as cancer, auto-immune diseases and rare diseases. We must act now,” says Prof Peter Piot, Director of the London School of Hygiene & Tropical Medicine and former head of UNAIDS.

“There is an incredible challenge for the sustainability of health systems across the world”, says Prof. Lucien Abenhaim, London School of Hygiene & Tropical Medicine and Chairman of Analytica Laser. “It is critical that drug developers and health system engage on actionable proposals that address concerns around value, cost and overall access to innovation for the patients who need it. We are at an inflection point – the paradigms of the 1990’s can no longer guide us,” he adds.

The main plenary on December 6th features scheduled remarks by over a dozen authorities in the field, including Professor Baron Peter Piot (Director, London School of Hygiene & Tropical Medicine and former Head, UNAIDS), Dr. Olivier Brandicourt (Chief Executive Officer, Sanofi), Dr. Sarah Garner (World Health Organization), Prof. Dominique Le Guludec (President, French HAS), Sir Andrew Dillon (Chief Executive, National Institute for Health and Care Excellence UK) and Dr. Harold Paz (Chief Medical Officer, Aetna). The plenary is preceded by a scientific seminar on December 5th which gathers globally renowned academics to explore new frontiers on the methodology for the appraisal and valuation of high-value medicines.

Please contact the organisers for more information on the programming and media access, or refer to www.accessibility-symposium.org

SOURCE: EuropaWire

MEDLAB Series Europe, 13-15 Sep 2017, will cover Point of Care Testing (POCT), Histopathology, Lab Management, Microbiology and Haematology

Spain, 04-May-2017 — /EuropaWire/ — After many years of operating successful MEDLAB events around Africa, Asia and the Middle East, Informa Life Sciences Exhibitions, the worlds leading publishing and exhibitions company, has announced that the MEDLAB Series will be expanding its presence into Europe. Taking place at the Barcelona Congress Centre in Barcelona, Spain, from 13-15 September 2017, more than 3,000 industry professionals are expected to attend Europe’s leading event for laboratory management and diagnosis.

With the European In-Vitro Diagnostics (IVD) market expected to reach USD 15.5 billion by 2024, a platform such as MEDLAB presents a huge opportunity for global laboratory industry leaders, including manufacturers, dealers and distributors, to make inroads into the European market. Housing international exhibitors and covering 2,000 sqm of exhibition space, MEDLAB Europe will give visitors from across the world an opportunity to access cutting-edge laboratory products, next-generation technology, innovative services and world-class educational content.

According to Tom Coleman, Group Exhibition Director, MEDLAB Series: “The launch of MEDLAB Europe is in line with our global expansion strategy for our MEDLAB series of events. The increasing prevalence of chronic diseases, rising geriatric population coupled with the rising awareness towards early diagnosis, has positioned the European IVD and medical laboratory market as a critical market for manufacturers, services providers, and dealers and distributors from across the globe. MEDLAB Europe will generate substantial value for our customers and partners by driving further product innovation and deeper engagement in these specific markets.”

Over the four-day event, MEDLAB Europe will also offer a multi-disciplinary congress tackling current challenges and developments key to the European market, and leveraging the true potential of laboratory testing to dramatically improve patient outcomes across the continent.

The conference programme covers five main tracks including Point of Care Testing (POCT), Histopathology, Lab Management, Microbiology and Haematology. From new methods of effective lab management to the development of techniques in detecting diseases, the conferences will also review the expanding role of the laboratory medicine and discuss partnership between a clinician and a lab professional in providing delivery of care to every patient.

“The scientific programme at MEDLAB has been carefully designed in collaboration with some of the brightest minds in the medical laboratory industry in order to have a real impact on improving the health and wellbeing of patients across the region,” said Coleman.

For more information about the MEDLAB Europe Exhibition & Congress, please visit: www.medlabeurope.com.

SOURCE: EuropaWire

Sway Medical’s app for sports concussion exam received European CE Mark as Medical Device

sway-concussiontest-is-a-validated-ios-app-based-concussion-management-system

TULSA, OK, 08-Sep-2016 — /EPR HEALTHCARE NEWS/ — Sway Medical is a US medical device company who’s software turns an iPhone or iPad into a mobile medical device that provides immediate medical grade, objective concussion measurement to medical professionals.

Sway Medical LLC (Sway) would like to announce its official availability in all European Union Countries. Sway was issued its CE Mark after being marketed in the United States and Canada for two years. This is significant because European sports organizations ranging from youth through pro level now have an affordable and convenient sideline assessment tool supporting concussion related medical decision making. Medical professionals and trained coaches can obtain a concussion assessment via an Apple mobile device (iPhone or iPad) and the Sway Balance™ System web-portal. Acute objective measurements are obtained by performing a 1.5 minute balance and reaction time test protocol. Licensed athletic trainers, physical therapists and athletic therapists are able to join physicians in acutely managing the underserved market of youth sports, ages six and older.

Concussion injuries are very common in sports, often going un-reported or ignored until the obvious symptoms have incapacitated the athlete or draws the attention of a parent or coach. Second Impact Syndrome (SIS) is a serious medical condition with published mortality rates of up to 50%. SIS occurs when an athlete returns to play while still recovering from an initial concussion injury. During this time, the brain is highly susceptible to additional injury and complications. The Sway Balance™ System is able to accurately assess and track the acute and chronic outcome related to an athlete’s balance, motion reaction time and concussion symptoms. The Sway Balance™ System provides a graphical representation comparing suspicious injury event tests against a pre-injury “normative” or baseline score. The comparison of event tests against an established baseline is a common measurement for traumatic brain injury diagnosis and recovery tracking.

The Sway Balance™ System is available for purchase by licensed medical professionals involved in school, occupational or sports medicine through www.swaymedical.com. Additional protocols are available to assess an individual’s “Fall Risk” or “Functional Status”.

SOURCE: EuropaWire

A New natural treatment for female infertility caused by tubal blockage and hydrosalpinx helps women conceive without painful surgery

Tubal blockage caused by inflammation, and hydrosalpinx, which are commonly used to be treated with surgery, such as laparoscopy, now can be cured with a new natural treatment – Fuyan pill – a herbal medicine invented by Dr. Lee who comes from Wuhan Dr. lee’s TCM clinic. It gives the hope for the female infertility to be conceived successfully.

Wuhan, CHINA, May 04, 2015 — /EPR HEALTHCARE NEWS/ — The Fuyan pill, based on ancient Chinese formulas for gynecological inflammations, which lasts for over 5000 years, is made from natural pure herbs without any chemical composition. According to the data from Wuhan Dr. Lee’s TCM Clinic, this natural herbal formula has cured hundreds of thousands women infertility who had suffered from tubal blockage led by inflammation, hydrosalpinx and their complications.

The inventor of this herbal medicine, Dr. Lee introduces: “This herbal medicine can cure inflammatory tubal blockage and hydropsalpinx without any other unpleasant procedures.” “Even for those had tried IVF to conceive unsuccessfully. Fuyan Pill also works on some of them when they try it as their last shot. According to our clinical cases, these diseases are commonly cured after three to four months medication. ” Dr. Lee says

Ada who had suffered from inflammatory tubal blockage for more than 3 years told us. “I had never been imaging that Fuyan Pill could work so fast that I got pregnant in third month medication. Well to be frank, taking the pills are not very pleasant experience, but doing these for 4 months is really worth my effort. I have been under a lot of pressure not being able to conceive, and I sometimes have even doubted the efficiency of this herb, because I feel nothing during the medication. However everything has changed after I got my ultrasound report after I finish 3 months pills. Dr. Lee has suggested me to take one more months pills after that in case it recurs and I have done as she’s recommended. The pill has made a huge difference and I am so grateful for what Dr. Lee has done.”

Chinese medicine owns outstanding sterilizing power to treat tubal blockage, especially, has special effects on hydrosalpinx. The pill can effectively cure these kinds of diseases without any side effects. It also contains prescription to clear away heat and toxic material, promote blood circulation, dissolve stasis, unblock the fallopian tubes and drive away the hydrops completely, which help to retrieve fallopian tube movements and clear the tube for the fertilization of eggs. Thus it could help patients conceive naturally without surgery. Patients could try pregnant after taking the medicine for 3 to 4 months.

Dr. Lee says, “Fuyan Pill has been widely used in our own clinic in China, the clinic states also show that it has been effectively cured women with inflammatory tube blockage and hydrosalpinx who don’t want to undergo surgery. It also has no postoperative problems, this really attractive for many women. So there are increasing number of women have benefitted from this magical medicine recent years. We really hope it could also help women infertility caused by inflammatory tubal blockage and hydrosalpinx from all over the world.”

About Dr. Lee Xiaoping and the herbal medicine:
Dr. Lee Xiaoping graduated from Hubei College of Traditional Chinese Medicine, China. She qualified as an herbalist 30 years ago and is a highly experienced medical professional. She specializes in the field of male and female reproductive and urinary system diseases. She has devoted 30 years to her clinic and worked on the formula of Fuyan Pill for years. The medicine has proven to be effective on treating tubal conditions. The formula is patented by SIPO (State Intellectual Property Office of the P.R.C) with the application number 201110031968.

For more details about DR. Lee and Wuhan Dr. Lee’s TCM Clinic, please kindly view http://www.drleetcmclinic.com/

Contact-Details:
Wuhan Dr. Lee
Telephone: +86-027-87105085
Email: herbalistlee@yahoo.com, wuhandrlee@hotmail.com
Website: http://global.fuyanpills.com/index.html

Via EPR Network
More Healthcare press releases

Healthcare Recruitment Expert Kevin Kirkpatrick Expands to Include More Than Just Physicians

Healthcare recruitment expert Kevin Kirkpatrick has averted his business focus from physicians to all members of the healthcare industry. While Avery Professional Group focused on building just teams of physicians, his new business TMA Healthcare Staffing will focus on building practices from the ground up.

TORONTO, March 2, 2015 — /EPR HEALTHCARE NEWS/ — Medical recruitment expert, Kevin Kirkpatrick has his sights set on more than physician recruitment. Branching off from the Avery Professional Group, Kirkpatrick has evolved into a full-fledged healthcare consulting firm, TMA Healthcare Staffing.

Instead of focusing on just placing physicians, TMA Healthcare Staffing will focus on the complete career span of all healthcare professionals, along with building practices and businesses from the ground up. TMA Healthcare Staffing offers potential clients expanded recruiting services and more administrative partnerships that can aid a healthcare professional at any point in their career.

“We are building off the previous experience of recruiting for hospitals such as the Peterborough Regional Health Centre and St Michael’s hospital in Toronto,” Kirkpatrick continued, “We believe there is a gap for organizations that can provide staffing services to the whole hospital and not just one area of it.”

About Kevin Kirkpatrick

Kevin Kirkpatrick is a seasoned professional with extensive experience in technology and healthcare recruitment. Combining both his academic credentials with his 15 years of recruiting and consulting experience, Kirkpatrick has the expertise to guarantee he is finding the best fit for an organization.

Kevin Kirkpatrick boasts 10 years in the healthcare recruiting industry, starting his own firm in 2008 and has developed invaluable relationships throughout the industry.

Contact

TMA Healthcare Staffing is currently working in a number of different cities both nationally and internationally to build accessible healthcare services for the communities.

For more information about recruiting or consulting services please contact:

Kevin Kirkpatrick
Managing Director/Founder
TMA Healthcare Staffing – A Donaldson & James affiliate.
Direct Toronto 1.905.419.1495 | toll free 1.855.568.7900 ext 842 | mobile 1.705.749.4853

Canada: Vancouver • Kelowna • Calgary • Edmonton • Winnipeg • London • Waterloo • Listowel • Hamilton • Mississauga • Toronto • Ottawa • Montreal • Halifax • St. John’s • UK | London • USA | Dallas • Houston • Austin • San Antonio• Charlotte

ViroCarb’s anti HIV Crowd Funding Campaign

Toronto, Canada, December 01, 2014 — /EPR HEALTHCARE NEWS/ — ViroCarb Inc. has launched a worldwide crowd funding campaign to promote the development of its new HIV infection inhibitor.

WORLD AIDS DAY – Make a donation to save lives from AIDS! Support new treatment development at: https://www.indiegogo.com/projects/funding-a-new-therapy-against-drug-resistant-hiv/x/9240077

Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.

The current treatment of HIV/AIDS involves the use of three or more drugs from five main general classes, used in combination. While this antiretroviral therapy (ART) has helped to reduced morbidity and mortality from AIDS, long term toxicity and the emergence and transmission of drug resistant HIV strains limit the effectiveness. Thus, despite therapy which can render this a chronic, rather than acute fatal infection, development of new drugs to prevent infection and overcome drug resistant strains, is increasingly urgent.

ViroCarb Inc. is developing a novel technology that addresses infections by drug resistant HIV strains. Developed from the identification of a new, natural resistance factor against HIV infection by scientists at SickKids and Canadian Blood Services, ViroCarb’s inhibitor works against a previously overlooked target on the virus to block HIV from entering human cells, the very first step in the infection. It works against all HIV strains.

Funds are needed to aid in moving forward to support preclinical studies; therefore ViroCarb Inc. has started an international crown funding campaign to carry out these HIV model studies needed before conducting clinical trials.
Please support this new way to block HIV.

Contact-Details: Dr. Mario Huesca
479 Simonston Boulevard.
Thornhill ON.
L3T 4M4 Canada

Facebook: https://www.facebook.com/ViroCarb;
Website: http://www.virocarb.com

 

Via EPR Network
More Healthcare press releases

Medical Scribe Systems Named to Inc. 5000 List for Fastest Growing Private Companies in America

Medical Scribe Systems (MSS) is recognized as one of America’s fastest growing private companies by Inc. magazine. MSS has doubled its growth every year since 2011, while also improving customer satisfaction.

El Segundo, CA – 2014-8-21 — /EPR Healthcare News/ —  Medical Scribe Systems (MSS), the nation’s leading provider of scribe programs specializing in revenue cycle enhancement, has been chosen for Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies, published annually by Inc. magazine.

Medical Scribe Systems
Medical Scribe Systems

“We are thrilled to have made such a prestigious list alongside other successful, hardworking organizations,” says CEO Garret Erskine. “It is a testament to the effectiveness of the MSS scribe program in improving physician productivity, clinical documentation, and patient satisfaction.”

“The company was started by four physicians with a simple idea,” says Erskine. “By offloading the data entry component of their work, they quickly discovered how to stay focused on patient care by positively impacting patient interaction, clinical efficiency, and the quality of documentation in the Electronic Medical Record (EMR).”

The recognition of MSS as one of Inc.’s “Fastest Growing Private Companies” comes at a time as the Company has doubled its client base within the last year, while at the same time improving customer satisfaction.  The company now has over 2,000 scribes serving nearly 100 facilities across the nation.

“MSS is focused on data integrity, charge capture, and revenue cycle solutions ensuring that our scribe program actually pays for itself,” says Erskine.  “Our unique approach integrates the scribe program into the customer’s Revenue Cycle and Clinical Documentation Improvement processes.  MSS partners with customers to address data quality issues at the time and point of care.”

For more information about Medical Scribe Systems, visit http://www.medicalscribesystems.com or email info@scribesystems.com.

About Medical Scribe Systems

Medical Scribe Systems, the nation’s leading provider of scribe programs focusing on revenue cycle enhancement, provides real-time documentation services for emergency departments, outpatient clinics, and hospitalists nationwide. The company founders are board-certified physicians who started their first scribe program in 2003. Board members Dr. Mark Richmond and Fred Brown, the former Chairman of The Joint Commission, helped establish the first guidelines for scribe use and compliance.  Now in nearly 100 hospitals nationwide and employing more than 2,000 scribes, Medical Scribe Systems has doubled growth each year since 2011.

Contact:
David Fong
Director of Marketing
dfong@scribesystems.com
(877) 819-5900

###

Medical Scribe Systems has doubled its growth every year since 2011. Today, the company employs about 2,000 scribes in nearly 100 hospitals and outpatient clinics nationwide.
Medical Scribe Systems has doubled its growth every year since 2011. Today, the company employs about 2,000 scribes in nearly 100 hospitals and outpatient clinics nationwide.
MSS medical scribes are becoming a best practice for clinical documentation on the Electronic Medical Record. They improve revenue cycle by capturing all billable elements in real time.
MSS medical scribes are becoming a best practice for clinical documentation on the Electronic Medical Record. They improve revenue cycle by capturing all billable elements in real time.

Health Gorilla Releases Mobile Application for Doctors

Digital Health Leader Expands Marketplace Access with Mobility

SUNNYVALE, CA., 2014-8-20 — /EPR Healthcare News/ — Health Gorilla™, Inc., the first online healthcare marketplace to connect doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers, has announced today the release of Health Gorilla mobile.  Health Gorilla mobile provides access to the Health Gorilla Marketplace through the Apple® iPhone® and iPad™.

Today over 68% of doctors have standardized on the Apple platform to communicate with peers and patients. Doctors can now use their mobile devices to place electronic orders with Health Gorilla mobile to diagnostic labs, radiology centers, physical therapy, skilled nursing facilities (SNFs) and durable medical equipment (DME) and other medical providers nationwide with the ability to track and review the results instantly as they arrive.  Physicians can then forward electronic results within their practice or exchange them with peers and patients to streamline the process and improve quality of care.

According to a study published by the New England Journal of Medicine noted that approximately 59.3% of all of a primary care physician’s daily emails were for the interpretation of test results and 21.7% were responses to patients.  The use of email generally increases the risk for doctors and their patients as most email services are not HIPAA compliant.

Another study published in the Journal of the American Medical Association (JAMA) reported that researchers from the Michael E. DeBakey Veterans Affairs Medical Center in Houston conducted a survey of primary care practitioners and found that a third reported missing alerts about test results from an electronic health record notification system designed to inform them when a patient has abnormal test results.

Doctors are adopting iPad and iPhones as the platform of choice to communicate with peers and patients. Health Gorilla mobile integrated messaging greatly reduces the risk in communication between a doctor and their patients by offering a fully HIPAA compliant environment. Health Gorilla mobile enables a physician to securely and compliantly forward diagnostic test results, radiology images, admission and discharge summaries and other clinical documents to patients and care coordinators through secure messaging.

Benefits of Health Gorilla Mobile Include:

  • HIPAA compliant and ONC modular certified MU2 solution
  • Order in less time than it takes to use fax forms
  • Receive results faster wherever you are
  • Forward results to patients instantly
  • Immediately refer results to another doctor and send messages
  • Eliminate error prone paper processes
  • Mobile solution available at no charge for doctors and their teams

“We believe that the value proposition is clear and compelling for doctors and their teams.” said Steve Yaskin, Chief Executive Office, Health Gorilla, Inc.  “The existing process is heavily dependent on paper, fax and manual processing.  It is slow, cumbersome and prone to error.  Doctors can better manage their time, and the time of their administrative and care coordinating teams, by using the power of the marketplace through the Health Gorilla app.  Now they have one place to order from any diagnostic lab, radiology center, hospital, physical therapy, sleep center, SNF and other healthcare providers in the United States.  A doctor can start with us the first day and begin ordering through the marketplace immediately.  Health Gorilla is the first to deliver this capability.  No other vendor can provide this benefit.”

Health Gorilla mobile is available as an approved Apple® enterprise application and will be distributed to existing Health Gorilla Marketplace users via a secure link for the next month.  In September Health Gorilla mobile app will be available from the Apple® store and will be fully integrated with the Apple® Health app upon its release.

About Health Gorilla
Health Gorilla™ is the first online healthcare marketplace to connect all doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers.  Doctors and their teams can instantly place orders, get results, and completely eliminate paper faxes. Uniquely, our HIPAA compliant and ONC modular certified MU2 solution is available immediately at absolutely no charge for doctors and clinicians.

Watch our 2 minute video Intro to Health Gorilla: http://youtu.be/6Luo5eNG8-s
Tweet: https://www.twitter.com/healthgorilla
Facebook: https://www.facebook.com/healthgorilla
LinkedIn: https://www.linkedin.com/company/2542523?
Sign-up for our Newsletter at the bottom of homepage:
http://www.healthgorilla.com

Contacts

For additional information contact Joe Austin via jaustin@theventanagroup.com or call 818-332-6166.

Health Gorilla™ is a trademark of Health Gorilla, Inc.
Apple®, iPhone®, iPad mini™ are trademarks of Apple, Inc.

Health Gorilla Releases Mobile Application for Doctors
Health Gorilla Releases Mobile Application for Doctors

HD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research Reached Agreement for Drug R&D Collaboration

HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.

“We are delighted to enter this partnership. The collaboration will leverage HDB’s extensive capabilities in preclinical drug discovery and development, and create long term potentials for the company.” stated Xuehai Tan, Ph.D., President & CEO of HDB. “In combination of CIBR’s expertise in drug development, we are confident to deliver novel drug candidates over the next few years, and to make this partnership a success.”

“Working with HDB gives CIBR a unique opportunity to showcase its strength in innovative drug discovery and development,” said Wuyi Meng, Ph.D., President of CIBR. “This partnership further demonstrates CIBR’s commitment in the betterment of patient’s lives by bringing forward novel medicines. We will collaborate closely with HDB to accelerate the progress of our collaborative programs”

About HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. is a Shanghai-based, biology-focused preclinical drug discovery contract research organization (CRO). The company offers comprehensive service platforms around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, as well as other research and development services. The company currently collaborates with eight of the ten largest pharmaceutical companies in the world and has established strategic partnerships on many key R&D areas with impacts to their portfolios. The strong scientific expertise, high quality and consistency in deliveries, constantly meeting or exceeding expectations, has earned the company a great reputation in the industry, and helped the company to build its widely recognized leadership in preclinical contract research services.http://www.hdbiosciences.com

About E. J. Corey Institute of Biomedical Research
Located in the Jiangyin High-tech Industry Development Zone in Jiangyin, Jiangsu, E. J. Corey Institute of Biomedical Research (CIBR) is a non-profit research organization founded by Nobel laureate Prof. E. J. Corey with the support from Jiangyin and Jiangsu government. CIBR is committed to scientific research in the broad biomedical field and to the development of novel therapeutics to meet the unmet medical needs of patients. In addition to its strong internal research and discovery capabilities in biomedical research and drug discovery, CIBR has established solid external capabilities in translational medicine and molecular toxicology to support drug development. Under the guidance of Nobel laureate Prof. Corey, CIBR is well poised to contribute to the discovery and development of novel medicines. http://www.cibrnobel.org

Contact Details:
HD Biosciences
Ms. Jessie Yang
Email: yangxiaojie@hdbiosciences.com

CIBR
Dr. Jiaquan Wu;
Email: jwu@cibrnobel.org

 

Via EPR Network
More Healthcare press releases

HD Biosciences and Anchor Therapeutics Form Collaboration for Co-marketing Pepducin-mediated GPCR Technology

HD Biosciences Co., Ltd (HDB) and Anchor Therapeutics, Inc. today announced that they have formed a strategic collaboration to co-develop and co-market Anchor’s proprietary pepducin technology and provide novel drug development solutions to global pharmaceutical companies with drug discovery efforts focused on G-protein coupled receptors (GPCR).

Pepducins are proprietary lipidated peptide modulators for GPCR signaling. They may stabilize receptor conformation, promote or inhibit dimerization, and modulate interaction of GPCR with signalosome. As a strong research tool, pepducin technology enables high throughput screening (HTS) campaigns for the identification of special class of compounds and allosteric ligands, facilitates biophysical studies via stabilization of GPCRs in different activation states and functionally de-orphanizes GPCRs to provide tools for interrogation of pharmacology in vitro and in vivo.

As a key component of HDB’s plate-based pharmacology service capabilities, GPCR assays and screenings is one of the most active research and development areas that attracts global clients and partners in drug discoveries. With over 200 recombinant GPCR cell lines in house, some of which are orphan receptors, combining a variety assay formats with pepducin technology allows HDB to enhance its capabilities for supporting hit identification, lead discovery and receptor selectivity profiling. The collaboration is also designed to provide broader exposure and accessibility of pepducin technology across pharmaceutical and biotechnology industries through HDB’s global client base. HDB’s clients will gain unprecedented access to not only the pepducin screening platform but also HDB-Anchor’s joint expertise in GPCR research.

“Anchor’s pepducin technology has provided a novel approach to search very special GPCR related compounds that have potential to alter the receptor functions. We believe this technology will be very valuable in GPCR related drug discovery.” commented Dr. Xuehai Tan, President and Chief Executive Officer of HDB. “As one of the global leaders in biology focused contract research services, HDB emphasizes on innovative and scientific driven technologies in order to deliver extra value to our clients. The partnership between HDB and Anchor is a perfect example to demonstrate our commitment to grow the expertise and strengthen our leadership in GPCR R&D.” Dr. Tan continues his comments.

“Anchor Therapeutics is extremely pleased to partner its pepducin technology with HD Biosciences, one of the leading companies providing state of the art high throughput screening services to pharmaceutical and biotechnology clients,” said Thomas J. McMurry, PhD, Anchor’s Interim President. Dr. McMurry continued, “Through this collaboration, Anchor and HDB will expand the validation of pepducin high throughput screening probes in order to provide HDB’s clients with access to innovative screens designed to facilitate access to novel small molecule pharmacophores.”

Via EPR Network
More Healthcare press releases

Innovative Drug Discovery Business, Biosortia Pharmaceuticals, Lands Two Health Care Veterans

Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.

Dieck has spent nearly 30 years in healthcare, including 18 years at Arthur Andersen as a global equity partner and then 10 years with Cardinal Health, a Fortune 20 public company, as a senior executive; there he worked with a broad spectrum of partners, including brand pharmaceutical manufacturers, throughout the supply chain. Dr. Guy Carter has over 30 years of experience working in pharmaceutical R&D, primarily in the discovery and development of microbial natural products. He previously was the leader of natural products drug discovery at Wyeth Research, as head of the Chemical Technologies Department.

“Kurt and Guy make a great team. Their complementary Pharma experiences and backgrounds create great opportunities to accelerate Biosortia’s objective to become the premier, aquatic natural products company with a primary focus in drug discovery,” says Ross Youngs, Biosortia’s Founder and Chairman. “Kurt and Guy bring a wealth of research and business experience along with deep industry relationships in building successful Pharma partnerships. Everyone involved with this young biotech is excited about the future.”

Industry observers have commented that late-stage R&D pipelines are not providing Pharma with the desired revenue growth the market is expecting. Therefore, large Pharma is evolving the way it performs R&D in order to optimize efficiency and to boost patent cliff defenses. These changes require shifting from relying solely on in-house chemistry-based R&D to acquiring and licensing external technologies and natural products based compounds in various stages of development. Biosortia’s ability to supply novel, highly active and potent compounds with drug-like characteristics will increase the productivity and success rate for Pharma as well as reduce the overall cost of the discovery process. The cost to discover, develop and launch a new drug is estimated to reach nearly $3B per drug by 2015. Biosortia’s business model is designed specifically to support Pharma’s needs.

“With nearly unlimited microorganisms (3.7 nonillion), the aquatic environment and its consortia represent an extraordinary opportunity…a new frontier, to access extremely potent and chemically diverse secondary metabolites with drug-like properties with unique mechanisms of action never researched before,” said Dieck. In describing the opportunity, Dieck goes on to say, “Biosortia is on the cutting edge of natural product discovery
and has the capabilities to deliver on its aspiration. Our powerful natural products research team, led by Dr. Guy Carter, in partnership with NOAA’s Dr. Peter Moeller, a leader in aquatic natural products research, has the experience and know-how to decipher the complex unexplored environment in a very efficient manner leveraging all the current state of the art instrumentation. The need for more efficient and effective approaches to drug discovery has never been more important. Biosortia’s innovative technologies, deep research skills and key relationships will efficiently provide thousands of unique natural products as candidates for drug discovery at a time when Pharma is in critical need for “high quality shots on goal.”

“Aquatic microbial consortia are a rich source of metabolically active organisms including microalgae, bacteria, fungi and their secondary metabolites,” states Carter. “Owing to the competitive nature of their habitat, chemical investigations of microbial consortia reveal unique structurally diversified natural products that are responsible for signaling and self-defense that have potential as therapeutics with novel mechanisms of action. Since they have been pre-optimized by nature, these compounds are typically closer to a drug candidate than a synthetic lead, thus requiring less optimization and shorter time when found as ‘hits’ in screening programs.”

The team has also focused on agreements with strategic collaboration partners as vital components to the strategy. Biosortia has recently entered into several collaboration agreements with NOAA, Analyticon and exclusive harvesting relationships, just to name a few. Several others will be advanced by the end of January. Biosortia’s cooperative research and development agreement (CRADA) with NOAA’s Center for Human Health Risk at Hollings Marine Laboratory provides a 5-year framework for research and development regarding the analysis and purification of novel bioactive compounds. According to NOAA’s Technology Partnerships Office, “Success will result in the commercial development of new and unique chemical compounds from the sea which have benefits to human health, either through disease prevention or new treatments for disease.”

Dr. Peter Moeller, NOAA’s Research Scientist who leads the Toxins Natural Products Program stated after analyzing fractions of Biosortia’s biomass, “Coupling NOAA’s mission of characterizing toxins affecting environmental and/or human health with Biosortia’s drug discovery focus turns one man’s toxin into another’s chemotherapeutic. The microorganisms analyzed in the Biosortia biomass identified more unique activity than I have seen in my 30 year career. The volumes achieved from a single harvest delivered an equivalent of 30 years of accumulation. This could materially change the landscape for natural products drug discovery research.”

As of December 31, 2012, Biosortia has identified more than 30 bioactive candidate compounds (hits) from a fresh water eutrophic lake consortium. Therapeutic areas of focus include treatments for cancer, infectious diseases, inflammation and neurological disorders. In addition, more than a dozen of its patent protected compounds are in initial evaluation stage within Eli Lilly’s Open Innovation Drug Discovery Program.

Dieck states, “Looking forward, it is with great optimism. We have a great team built around mutual respect, deep experience, and a desire to succeed and make a difference. We are aligning with the right partners and collaborators to execute our strategy with speed and discipline to provide Pharma with much high quality & diverse compounds vs. “me-too” drugs than they have had in the past 10 years. We are excited about what this company can accomplish, not only for its shareholders but also for the millions of people who have been diagnosed with various forms of chronic diseases who are looking for Pharma to identify better ways to help them extend their lives or live a more productive life. Biosortia can play a big role in identifying compounds that can help Pharma achieve these goals. I am looking forward to the challenge and opportunity to build an industry leading drug discovery company.”

Via EPR Network
More Healthcare press releases

Vitamin D Pharmacy’s YouTube Video Surpasses the 2000 View Mark as Winter Sets in and the Hours of Vitamin D Producing Sunshine Decrease

New Life Pharmacy in Glasgow is on a mission to raise awareness of vitamin D deficiency and in turn, reduce the number of people suffering from its related health issues.

In April 2012 Elizabeth Roddick, Fellow of the Royal Pharmaceutical Society of Great Britain, pharmacist and owner of the New Life Pharmacy released a video on YouTube that explains the health risks of being deficient in vitamin D. Low levels of this important vitamin have been linked with diabetes, arthritis, high blood pressure, hypothyroidism and cancer.

More recently, studies have found that a high level of vitamin D in women under the age of 75 can decrease the risk of macular degeneration and the loss of central vision, which is a main cause of partial-blindness in people over 50 years old (Qureshah, 2012). Vitamin D deficiency can also lead to health issues and diseases such as rickets, multiple sclerosis, depression and respiratory tract infections.

Vitamin D is produced when ultra violet (UVB) rays coming from the sun hit the skin. It is then absorbed through the liver where it is converted to calcidiol. It then works to check the calcium and phosphate levels in the blood, which are important for maintaining healthy bones. Vitamin D can also be found in some foods such as eggs, oily fish and fortified cereals.

It is common knowledge that all people’s vitamin D levels drop during the winter (November to March) as the sun is weaker during this time. A recent study (Qureshah, 2012) found that during the winter 28 percent of women had deficient levels of vitamin D, and 33 percent of women had insufficient levels. Being regarded as deficient means the level of vitamin D is less than 20ng/mL, insufficient is having 20-29ng/mL. Compare this with the summer statistics where only 5% are deficient in vitamin D and the contrast is clear.

According to Roddick, the skin needs to be exposed at the hottest time of the day (between 10am and 3pm) for about 15 minutes. These are the hours where the UVB rays are strongest and so vitamin D is most prevalent. This of course completely opposes the advice given out by skin cancer charities who urge sun bathers and holiday makers to stay out of the sun during these peak hours. Roddick does add, “It is of course very important than the skin does not burn since that can lead to skin cancer.”

Roddick believes that, “supplementation is required for most people. Also, because there are certain people who shouldn’t take vitamin D and a wide range of doses are available it can be confusing. Advice needs to be available when purchasing the products.”

Via EPR Network
More Healthcare press releases

Boots UK and Macmillan Cancer Support launch new role to help millions access cancer information

According to new research* almost a third of people affected by cancer felt that they had insufficient information and support outside of their healthcare team. Boots UK and Macmillan have specially trained over 500 Boots Macmillan Information Pharmacists to help improve the lives of those affected by cancer**. They will be available in many Boots stores to help connect people to information and support in their local area.

The launch of the Boots Macmillan Information Pharmacist is the first time that the role of a pharmacist has been extended to include this type of cancer information and support. It is estimated that 2 million people are currently living with or beyond cancer in the UK and this is anticipated to increase to 4 million by 2030***. As the demand for cancer health care is set to rise, the launch of this innovative pharmacy role aims to help the millions of people affected by cancer access the information and support they need, in an accessible and trusted environment.

Ciarán Devane, Chief Executive of Macmillan, commented: “The Boots Macmillan Information Pharmacists are the next stage in what is already a strong and sector-leading partnership that we both are extremely proud of. Macmillan and Boots UK believe that by sharing expertise and working together, we can reach even more of the millions of people affected by cancer than we are currently.”

The research also showed that nearly three quarters (74%) of people living with cancer felt that the information and support they received outside of their healthcare team made them better equipped to understand their cancer experience:
– 92% felt it had a positive impact on their emotional, physical or financial well being
– 51% felt able to understand more about their cancer and their experience of it
– 48% felt able to make decisions that were right for them

Alex Gourlay, Chief Executive of Health & Beauty Division, Alliance Boots, added:
“The introduction of the Boots Macmillan Information Pharmacist means that for the millions of customers that visit Boots pharmacies across the country, they can access increased cancer information and support. The findings from this research highlight just how important accessing the right information at the right time can be for people affected by cancer and the role it can play in helping them to manage their condition.”

Visit www.boots.com/cancer to find your nearest Boots Macmillan Information Pharmacist. For cancer support contact Macmillan on 0808 808 0000 or visit www.macmillan.org.uk.

Via EPR Network
More Healthcare press releases

New Study Suggests Alcohol Abuse Rewires Brain, Impedes Trauma Recovery

A recently published study suggests that heavy alcohol use may interfere with recovery from traumatic situations.

The study was published in the journal Nature Neuroscience and focused on mice that were chronically exposed to alcohol in doses twice the legal driving limit imposed on humans. Conversely, the control group of mice wasn’t exposed to any alcohol. After administering, and then ceasing, tiny electrical shocks mimicking trauma within humans, the mice chronically exposed to excessive alcohol had a more difficult time recovering from the trauma. In addition, a key receptor within the brains of the alcohol-exposed mice was suppressed and nerve cells within the brain were found to have taken on a different shape.

“This study offers valuable insight into how chronic alcohol abuse may disrupt recovery pathways in human brains,” begins a spokesperson for Mountainside Drug Rehab andAlcohol Treatment Center. “By understanding the correlation between chronic alcohol abuse and anxiety associated with traumatic events, researchers could eventually develop drugs that could assist in recovery for chronic alcohol abusers.”

The Centers for Disease Control and Prevention states that excessive alcohol use is the third leading lifestyle-related cause of death within the United States, estimating nearly 80,000 deaths annually. If you fear that a loved one may be excessively consuming alcohol, Mountainside Drug Rehab and Alcohol Treatment Center can assist them in getting their life back on track. Mountainside’s comprehensive alcohol rehab program has been recognized as a standout program among their peers.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab and alcoholism treatment facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also has available services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program and its professional addiction treatment team have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential discussion at 800-762-5433.

Via EPR Network
More Healthcare press releases

BootsWebMD.com launches Baby Personality Quiz

BootsWebMD.com has launched a new, online Baby Personality Quiz which highlights several key traits to look out for when analysing a baby’s temperament.

With the help of the Baby Personality Quiz* on the BootsWebMD.com Children and Parenting Health Centre, users can identify their baby’s personality by answering a series of simple questions about their behaviour. The results of the quiz can then be analysed to identify their behaviour patterns. Essential information about the best approach in managing a child’s behaviour habits can also be found, with a simple step-by-step guide to keeping in sync with the baby. It could even help users to work in tandem with their child’s temperament and personality to make life easier for both parent and child.

Whether the child is feisty or easy-going, the answer to identifying its personality and behaviour patterns lies in a number of key areas. According to paediatrician Dr William Carey, author of ‘Understanding Your Child’s Temperament’, these include:

Activity/energy level – if the child has high or low energy levels, parents need to look for ways to keep them moving at a pace that’s comfortable for them Approach to newness – a naturally hesitant or shy baby will need extra reassurance and patience to overcome their shyness.

Intensity – if a baby is laid back, they can get lost in the shuffle of family life and vice versa. If the baby is intense they must be taught to deal with the curves of life

Sensitivity – if a baby has high sensitivity to lights, noise or texture, parents must be patient and look for ways to avoid sensory overload such as the lighting and the type of clothes the baby wears.

Regularity – if everything is unpredictable, potty, naps, moods, parents have to let go of their controlling ways and loosen up. Conversely, if a baby likes structure, parents might have to adhere to the schedule they crave

Persistence – puzzles are great tools to lengthen attention span, along with a daily dose of bedtime reading.

Overall mood – parents should take the time to observe their baby’s daily patterns and what makes them smile for a happier baby.

Via EPR Network
More Healthcare press releases

Drug-Related Deaths Outnumber Deaths By Automobile Accident

The Centers For Disease Control (CDC) has declared prescription drug overdoses as an epidemic in the United States.

The CDC estimates that one death from abuse of prescription drugs happens every 19 minutes- a greater number than those killed in automobile accidents. The National Institute of Health estimates that nearly ten percent of Americans abuse narcotics over their lifetime; 20% of teens are estimated to be experimenting with opioids.

“The number of individuals who experiment with narcotics is alarming,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “It seems as if many individuals believe that experimenting with narcotics is safe simply because they are prescribed by a physician and filled at a pharmacy. These statistics show that these beliefs couldn’t be further from the truth. Prescription drugs are prescribed by a physician, or other qualified medical professional, for a specific individual – others abusing them are endangering their lives. We need to make certain that we are sending the right message, all of the time, to Americans. We must be vigilant as we declare war on this epidemic.”

While opioid abuse is growing at a staggering rate, there is hope. If you believe that your child or other loved one is among those who are experimenting with opioids or any other substance, Mountainside Drug Rehab and Alcohol Treatment Center can help provide professional intervention services that will help you to approach them in a non-confrontational manner.

Through their unique drug addiction treatment program, Mountainside’s team of professionals will customize a program that is unique to the specific treatment needs of the individual. In addition, their comprehensive family care program will educate the entire family as well and give them the tools to support the family member’s recovery process leading to the journey of life-long sobriety.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also has available services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

Via EPR Network
More Healthcare press releases

New Research Suggests Addiction to Opioids May be Preventable

A new study suggests that in the future it may be possible to eliminate possible addiction to opioids while increasing the pain relief that those medications provide.

A joint study conducted by researchers from the University of Adelaide in Australia and the University of Colorado focused on the body’s immune system response to opioids and, in particular, an immune receptor termed TLR4. This particular receptor allows the opioids to be bound to it and, by doing so, drives the physiological reward system. Researchers discovered that by creating a drug that blocks this receptor, opioids are prevented from driving the physiological reward system.

Another benefit was also discovered during this research phase. In addition to blocking the reward system pathways, researchers also discovered that the effectiveness of the opioids pain relief mechanisms also increased.

“This study deserves much consideration,” begins a spokesperson for Mountainside DrugRehab and Alcohol Treatment Center. “If it is develops that being able to increase the effectiveness of the pain relief properties of opioids while, at the same time, preventing the reward system from being activated, it will mean that those taking various pain medications will be on a safer journey.”

Statistics from the National Institute of Health estimates that nearly ten percent of Americans abuse opioids over the course of their lifetime, with one in five children experimenting with opioids prior to their seventeenth birthday. If you believe that your child is among that twenty percent and are in need of assistance in reaching your child, Mountainside Drug Rehab and Alcohol Treatment Center can help provide professional intervention services that will help you to approach your child in a non-confrontational manner.

Through their unique drug addiction treatment program, Mountainside’s team of professionals will customize a program that is unique to the specific treatment needs of the individual. In addition, their comprehensive family care program will educate the entire family as well and give them the tools to support the family member’s recovery process leading to the journey of life-long sobriety.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also has available services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases

Alcohol abuse may be predictable in future

A new study conducted by researchers at the University of California found that future prediction of alcohol abuse might be possible.

MRI scans were performed on 40 adolescents who had never drank alcohol and found that the children who had been followed, initially, showed less activity in specific areas of the brain and were at potential risk for becoming heavy drinkers.

“While this study followed adolescents, it provided valuable insight into the brain’s mechanisms,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “Certainly, this study doesn’t advocate brain scans for adolescents, but research into the way these specific areas of the brain function may be able to help those within the addiction field to look into means for advanced prevention for alcohol abuse in the future within a variety of ages of individuals.”

Prevention, beginning at a young age, is the key to decreasing alcohol abuse in America.

As a parent, you may find it difficult to approach your child about issues relating to alcohol or to their drinking. However, if you suspect that your young adult is struggling with underage drinking, Mountainside Drug Rehab and Alcohol Treatment Center can help you gently and effectively approach them with their customized, professional intervention services.

Through their unique alcohol rehab treatment program, their team of professionals will customize a program that’s unique to the specific treatment needs of the individual. Their comprehensive family care program will educate the individual and his/her family and provide the necessary tools to support the recovery process.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also has available services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities that Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases

New FDA Regulations Require More Of Opioid Drug Makers

In an effort to help decrease the number of deaths related to opioid overdose, the FDA is requiring pharmaceutical companies that manufacture opioids to help fund training programs for medical professionals. Along with the training funding, drug makers will also be required to provide safety pamphlets to patients explaining the risks and interactions of the opioids.

“The FDA’s new measure will hopefully prove to be an effective means to decrease overdose due to the misuse of prescription drugs,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center . “Education of patients is particularly important. Some may think that the risk of overdose and the misuse of narcotics are widely known. However, we believe that some individuals still believe that taking just a few extra pills can’t hurt. In fact, that’s simply not true; taking a few extra pills can be the difference between life and death.”

In the past decade, overdose death rates within the United States have more than tripled. While a narcotic addiction can start off innocently, it can quickly become an acute, dangerous addiction. If you are concerned that your narcotic use may be spiraling out of control, Mountainside Drug Rehab and Alcohol Treatment Center can help you get, and stay, on the road to recovery. Through their unique addiction treatment program, their team of professionals will customize a program that’s unique to your specific treatment needs. Their comprehensive family care program will educate your family as well and give them the tools to support your recovery process and help you on your journey to life-long sobriety.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also provides services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases

July 4 Is Among The Most Deadly Holidays In The US

While many are celebrating the anniversary of the independence of the United States, others are suffering tragedy.

The state of Louisiana reports that more than half of their state’s motor vehicle crashes occur during the Fourth of July holiday, and the numbers increase annually.

“Many states report the same tragic situation that takes place in Louisiana,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “Fortunately, in response to the growing number of fatal motor vehicle accidents, Highway Patrols in many states are setting up additional sobriety checkpoints and saturation patrols during this holiday period, as well as other holiday periods. While these methods certainly have the potential to reduce fatalities, the best method is to be pro-active with prevention.”

Tips for being pro-active in prevention for the Fourth of July holiday:

•  Designate yourself as the sober driver. Don’t wait for someone to volunteer to become the designated driver. Let your friends know that you are the point of contact for all transportation needs during the Fourth of July celebratory events.

•  Limit the amount of alcohol served to everyone. Limiting the number of drinks served to everyone changes the atmosphere of the party from one of intoxicated people to one in which everyone is having fun and not getting intoxicated.

•  Make plans to stay put. While this may seem like an extreme measure, if you’re hosting a celebration, arrange for a place for some guests to crash in the event they drink too much.

Holiday times can be a particularly challenging and eye-opening time for those who abuse drugs and alcohol and can be used as a catalyst for change in the life of an addicted individual. If you are interested in helping a friend or loved one recover from their addiction, Mountainside Drug Rehab and Alcohol Treatment Center can assist you with professional intervention services. Upon admission, Mountainside will help create an individualized drug and alcohol abuse program that fits each individual’s needs and helps them get on the road to a sober life. In addition, its comprehensive family care program gives you and your family the tools needed to help support you in your recovery journey.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside also provides services for those individuals who come to them with dual diagnoses and require the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433.

Via EPR Network
More Healthcare press releases